Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease

Acute myeloid leukemia (AML) infrequently involves the central nervous system (CNS). This study was undertaken in patients with AML to determine whether cytogenetic findings predict CNS involvement.

[1]  J. Bennett,et al.  B-Lymphoblastic Leukemia/Lymphoma , 2014 .

[2]  R. Storb,et al.  Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement. , 2011, International journal of radiation oncology, biology, physics.

[3]  D. Johnston,et al.  The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: A Children's Oncology Group study , 2010, Pediatric blood & cancer.

[4]  H. Kantarjian,et al.  Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy. , 2009, Blood.

[5]  J. Downing,et al.  Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1 , 2009, Leukemia.

[6]  T. Naoe,et al.  Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates. , 2007, Leukemia research.

[7]  J. P. Meza-Espinoza,et al.  Use of the International System for Human Cytogenetic Nomenclature (ISCN). , 2006, Blood.

[8]  D. Johnston,et al.  Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Hong Chang,et al.  Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. , 2004, Leukemia research.

[10]  G. Gatta,et al.  Adult acute lymphoblastic leukaemia. , 2004, Critical reviews in oncology/hematology.

[11]  C. Pui.  Toward optimal central nervous system-directed treatment in childhood acute lymphoblastic leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Höglund,et al.  Acute myeloid leukemia with inv(16)(p13q22): Involvement of cervical lymph nodes and tonsils is common and may be a negative prognostic sign , 2002, American journal of hematology.

[13]  C. Bloomfield,et al.  Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). , 2002, Blood.

[14]  D. Hoelzer,et al.  Recent approaches in acute lymphoblastic leukemia in adults. , 2000, Reviews in clinical and experimental hematology.

[15]  K Wheatley,et al.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.

[16]  C. Bloomfield,et al.  Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. , 1998, Cancer research.

[17]  M. Tribalto,et al.  Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia. , 1993, Cancer genetics and cytogenetics.

[18]  C. Bloomfield,et al.  Central nervous system involvement in acute nonlymphocytic leukemia. A prospective study of adults in remission. , 1987, The American journal of medicine.

[19]  R. Larson,et al.  Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. , 1986, Blood.

[20]  A. Cork,et al.  A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). , 1985, Blood.

[21]  C. Bloomfield,et al.  Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.

[22]  A. Cork,et al.  Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia. , 1979, Blood.

[23]  Y. Bertrand,et al.  Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group study 58881. , 2011, European journal of cancer.

[24]  L. Shaffer,et al.  Comprar ISCN 2009 - An International System for Human Cytogenetic Nomenclature | Marilyn L. Slovak | 9783805589857 | Karger AG , 2009 .

[25]  M. Slovak,et al.  Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. , 2000, Blood.

[26]  P. Bolufer,et al.  Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement. , 2000, Haematologica.

[27]  C. Bloomfield,et al.  Fourth International Workshop on Chromosomes in Leukemia 1982: Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.